| Name | Title | Contact Details |
|---|
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.
IDS Limited is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
California Transplant Svc Inc is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vegreville and District Family and Community Support Services is a Vegreville, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DNA2.0 is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Menlo Park, CA. To find more information about DNA2.0, please visit www.dnatwopointo.com